- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Venmax Drugs & Pharmaceuticals has announced a board meeting on which approved the financial results for the quarter and half-year. Revenue from operations stood at Rs. 33.28 lakhs for the quarter and Rs. 80.73 lakhs for the year, with total revenue including other income at Rs. 135.60 lakhs for the quarter and Rs. 186.05 lakhs for the year. The company reported a profit before tax of Rs. 77.49 lakhs for the quarter but a slight loss of Rs. 1.41 lakhs for the year. Earnings per share were Rs. 1.485 (basic and diluted) for the quarter and negative Rs. 0.02 for the year. The company also received 25% proceeds towards the preferential issue of over 1 crore convertible equity share warrants to non-promoters, significantly boosting cash reserves to Rs. 248.24 lakhs from Rs. 0.25 lakhs. The auditors issued an unmodified opinion on the audited financials.